Vasohibin-1, a Negative Feedback Regulator of Angiogenesis, Ameliorates Renal Alterations in a Mouse Model of Diabetic Nephropathy

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
doi 10.4044/joma.123.19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Okayama Medical Association

Related search

Vasohibin: The Feedback on a New Inhibitor of Angiogenesis

Journal of Clinical Investigation
Medicine
2004English

Wenshen Jianpi Recipe, a Blended Traditional Chinese Medicine, Ameliorates Proteinuria and Renal Injury in a Rat Model of Diabetic Nephropathy

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2019English

The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2018English

Exogenous Lipocalin 2 Ameliorates Acute Rejection in a Mouse Model of Renal Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2015English

Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Resveratrol Ameliorates Diabetic Nephropathy in Rats Through Negative Regulation of the P38 MAPK/TGF-β1 Pathway

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Pathogenesis of Renal Injury in the Megabladder Mouse: A Genetic Model of Congenital Obstructive Nephropathy

Pediatric Research
Child HealthPediatricsPerinatology
2010English

Signal Transducer and Activator of Transcription 1 Activation in Endothelial Cells Is a Negative Regulator of Angiogenesis

Cancer Research
Cancer ResearchOncology
2006English

Vasohibin-1 Expression in Endothelium of Tumor Blood Vessels Regulates Angiogenesis

American Journal of Pathology
Forensic MedicinePathology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy